DE602006021048D1 - Behandlung von akutem nierenversagen mit löslichem thrombomodulin - Google Patents

Behandlung von akutem nierenversagen mit löslichem thrombomodulin

Info

Publication number
DE602006021048D1
DE602006021048D1 DE602006021048T DE602006021048T DE602006021048D1 DE 602006021048 D1 DE602006021048 D1 DE 602006021048D1 DE 602006021048 T DE602006021048 T DE 602006021048T DE 602006021048 T DE602006021048 T DE 602006021048T DE 602006021048 D1 DE602006021048 D1 DE 602006021048D1
Authority
DE
Germany
Prior art keywords
soluble thrombomodulin
treatment
kidney failure
acute kidney
thrombomodulin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006021048T
Other languages
English (en)
Inventor
Brian William Grinnell
Thurman Dwight Mckinney
Bruce A Molitoris
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of DE602006021048D1 publication Critical patent/DE602006021048D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE602006021048T 2005-10-13 2006-10-12 Behandlung von akutem nierenversagen mit löslichem thrombomodulin Active DE602006021048D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72637605P 2005-10-13 2005-10-13
PCT/US2006/040069 WO2007047430A2 (en) 2005-10-13 2006-10-12 Method of treating acute failure with thrombomodulin variant

Publications (1)

Publication Number Publication Date
DE602006021048D1 true DE602006021048D1 (de) 2011-05-12

Family

ID=37670944

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006021048T Active DE602006021048D1 (de) 2005-10-13 2006-10-12 Behandlung von akutem nierenversagen mit löslichem thrombomodulin

Country Status (13)

Country Link
US (1) US20080255047A1 (de)
EP (1) EP1948216B1 (de)
JP (1) JP5405829B2 (de)
AT (1) ATE503489T1 (de)
CA (1) CA2625888C (de)
CY (1) CY1112438T1 (de)
DE (1) DE602006021048D1 (de)
DK (1) DK1948216T3 (de)
ES (1) ES2360610T3 (de)
PL (1) PL1948216T3 (de)
PT (1) PT1948216E (de)
SI (1) SI1948216T1 (de)
WO (1) WO2007047430A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2104508A2 (de) 2006-12-12 2009-09-30 Eli Lilly And Company Behandlung von akutem nierenversagen mit löslichen thrombomodulin-varianten
EP2355839A2 (de) * 2008-11-12 2011-08-17 Eli Lilly and Company Zusammensetzungen und verfahren zur verwendung für lösliche thrombomodulin-varianten

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2022713A1 (en) * 1989-08-11 1991-02-12 Nils U. Bang Human thrombomodulin derivatives
WO1993015755A1 (en) * 1992-02-05 1993-08-19 Schering Aktiengesellschaft Protease-resistant thrombomodulin analogs
AU692497B2 (en) * 1993-12-17 1998-06-11 Asahi Kasei Pharma Corporation Soluble thrombomodulin-containing pharmaceutical composition
WO2004076635A2 (en) * 2003-02-25 2004-09-10 Biovec B.V. Therapeutic applications of thrombomodulin gene via viral and non-viral vectors

Also Published As

Publication number Publication date
CY1112438T1 (el) 2015-12-09
WO2007047430A2 (en) 2007-04-26
SI1948216T1 (sl) 2011-07-29
JP2009511597A (ja) 2009-03-19
ES2360610T3 (es) 2011-06-07
WO2007047430A8 (en) 2008-04-10
US20080255047A1 (en) 2008-10-16
ATE503489T1 (de) 2011-04-15
CA2625888A1 (en) 2007-04-26
WO2007047430A3 (en) 2007-05-24
PT1948216E (pt) 2011-05-06
PL1948216T3 (pl) 2011-10-31
DK1948216T3 (da) 2011-06-06
EP1948216A2 (de) 2008-07-30
EP1948216B1 (de) 2011-03-30
JP5405829B2 (ja) 2014-02-05
CA2625888C (en) 2015-09-22

Similar Documents

Publication Publication Date Title
CY1120022T1 (el) Θεραπεια παιδιατρικης οξειας λεμφοβλαστικης λευχαιμιας
EA201000630A1 (ru) Применение бензоконденсированных гетероциклических сульфамидных производных для понижения уровней липидов в крови
EA200701845A1 (ru) Рофлумиласт для лечения сахарного диабета
BR0308928A (pt) Uso de toxina botulìnica para o tratamento de doenças cardiovasculares, bem como composição para uso em um procedimento cardiovascular
ATE548035T1 (de) Formulierungen zur behandlung von lipoprotein- anormalitäten mit einem statin- und einem methylnicotinamid-derivat
EA200870091A1 (ru) Применение бензоконденсированных гетероциклических сульфамидных производных для снятия боли
HRP20110969T1 (en) Pimobendan to be used for the reduction of heart size in mammals suffering from heart failure
EA200601776A1 (ru) Метадоновые композиции местного действия и способы их применения
WO2009044173A3 (en) Methods of treating cancer using notch pathway inhibitors
CY1109191T1 (el) Μια νεα χρηση της δεφεριπρονης
ATE543492T1 (de) Behandlung von lungenkrebs
EA200702026A1 (ru) Лечение или предупреждение зуда
DE60305068D1 (de) Behandlung von mastalgie mit4-hydroxy-tamoxifen
DE602006021048D1 (de) Behandlung von akutem nierenversagen mit löslichem thrombomodulin
EP2754447A3 (de) Behandlung von akutem nierenversagen mit löslichen thrombomodulin varianten
DE50111407D1 (de) Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen
TN2011000206A1 (en) Compositions and methods of use soluble thrombomodulin variants
FI20030015A0 (fi) Menetelmä munuaisten vajaatoiminnan hoitamiseksi
RU2005129591A (ru) Способ лечения хронической сердечной недостаточности
ATE546137T1 (de) Pharmazeutische zusammensetzungen zur behandlung von warzen
BRPI0519661A2 (pt) uso de agonistas de ppar para o tratamento da falÊncia cardÍaca congestiva
DE60143390D1 (de) Methode zur behandlung von herzinsuffizienz
RU2004102562A (ru) Способ лечения ограниченной склеродермии
DK1962822T3 (da) Terapi af maligne neoplasier
RU2004104555A (ru) Способ лечения диабетической ретинопатии, осложненной гемофтальмом